Date: 2014-11-04
Type of information: Opening of new premises
Compound: heart-lung machines, autotransfusion systems
Company: Sorin (Italy)
Therapeutic area: Cardiovascular diseases
Type agreement:
Action mechanism:
Disease:
Details: * On October 24, 2014, Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced it has expanded its Munich manufacturing facility to accommodate growing worldwide demand for state-of-the-art cardiopulmonary technology. The expansion will increase the size of the current facility by 25 percent to approximately 11,000 square meters, including offices, laboratories and training facilities. The manufacturing floor space extension will allow the production capacity of heart-lung machines (HLM) and autotransfusion systems (ATS) to be significantly increased and it will enable the in-house manufacturing of heater-cooler systems. The company’s Munich facility produces advanced cardiopulmonary systems, including hundreds of HLMs, ATS machines and blood-gas monitoring devices each year. In addition to its German plant, Sorin Group operates facilities dedicated to cardiopulmonary bypass systems in Denver, Colorado, U.S.A. and in Mirandola, Italy. In 2013, the company also started a greenfield manufacturing project in China to better serve the growing demands of the Chinese medical community.
Financial terms:
Latest news:
